Cannabinoids and glaucoma

I. Tomida; Roger Guy Pertwee; Augusto Azuara-Blanco

doi:10.1136/bjo.2003.032250

Cannabinoids and glaucoma

I. Tomida, Roger Guy Pertwee, Augusto Azuara-Blanco

Medical Sciences

Research output: Contribution to journal › Article › peer-review

123 Citations (Scopus)

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Original language	English
Pages (from-to)	708-713
Number of pages	5
Journal	British Journal of Ophthalmology
Volume	88
Issue number	5
DOIs	https://doi.org/10.1136/bjo.2003.032250
Publication status	Published - May 2004

Keywords

INTRAOCULAR-PRESSURE
NORMOTENSIVE RABBITS
NEUROPROTECTIVE ANTIOXIDANTS
TOURETTES-SYNDROME
RECEPTOR AGONISTS
MARIHUANA SMOKING
OCULAR TOXICITY
CILIARY BODY
HUMAN EYES
DELTA-9-TETRAHYDROCANNABINOL

Access to Document

10.1136/bjo.2003.032250

Cite this

@article{0adb498e1b9348bf8996dc9470d3efe0,

title = "Cannabinoids and glaucoma",

abstract = "Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.",

keywords = "INTRAOCULAR-PRESSURE, NORMOTENSIVE RABBITS, NEUROPROTECTIVE ANTIOXIDANTS, TOURETTES-SYNDROME, RECEPTOR AGONISTS, MARIHUANA SMOKING, OCULAR TOXICITY, CILIARY BODY, HUMAN EYES, DELTA-9-TETRAHYDROCANNABINOL",

author = "I. Tomida and Pertwee, {Roger Guy} and Augusto Azuara-Blanco",

year = "2004",

month = may,

doi = "10.1136/bjo.2003.032250",

language = "English",

volume = "88",

pages = "708--713",

journal = "British Journal of Ophthalmology",

issn = "0007-1161",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Cannabinoids and glaucoma

AU - Tomida, I.

AU - Pertwee, Roger Guy

AU - Azuara-Blanco, Augusto

PY - 2004/5

Y1 - 2004/5

N2 - Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

AB - Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

KW - INTRAOCULAR-PRESSURE

KW - NORMOTENSIVE RABBITS

KW - NEUROPROTECTIVE ANTIOXIDANTS

KW - TOURETTES-SYNDROME

KW - RECEPTOR AGONISTS

KW - MARIHUANA SMOKING

KW - OCULAR TOXICITY

KW - CILIARY BODY

KW - HUMAN EYES

KW - DELTA-9-TETRAHYDROCANNABINOL

U2 - 10.1136/bjo.2003.032250

DO - 10.1136/bjo.2003.032250

M3 - Article

SN - 0007-1161

VL - 88

SP - 708

EP - 713

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

IS - 5

ER -

Cannabinoids and glaucoma

Abstract

Keywords

Access to Document

Fingerprint

Cite this